Rise in Cases of Skin Cancer Accelerating the Skin Graft treatment

Publisher: The Insight Partners

In recent years, there has been a rise in the cases of skin cancer as well as diabetes. Diabetes is among the most common disorders prevalent across the globe. The number of diabetic patients has increased rapidly in regions such as India, China and United States among others. The process of wound healing in diabetic patients is a long process, which also increases the risk of skin infections. As per a report published by Diabetes UK in December 2014, around 3.24 million people living with have been diagnosed with diabetes in the UK and estimated to reach 5 million by 2025. Skin cancer has become highly prevalent across the globe. Most of the skin cancers caused are due to the exposure to the sun. Other factors such as, lowered immunity, previous radiotherapy treatment, overexposure to chemicals at work and rare genetic conditions. As per data released by Cancer Research UK, there are around 15,400 new melanoma skin cancer cases in the UK every day, during 2013 to 2015. Skin grafts are preferred post-surgery in skin cancers. Hence, the rise in cases of skin cancer and diabetes are expected to drive the market of skin grafts during the forecast period.

The major players operating in the market for skin graft across the globe include:Smith & Nephew, Mimedex, Tissue Regenix, Integra Lifesciences Corporation, Organogenesis, Inc., Zimmer Biomet, Nouvag, De Soutter Medical, Braun Melsungen AG, and Avita Medical among others.

The skin graft market is segmented on the basis of type, graft thickness, equipment, application, and end user. Based on type, the market is segmented into autologous, allogeneic, xenogeneic, prosthetic, and isogeneic. In 2017, the autologous segment held the largest share of the market, since it can be obtained from the same patient. On the basis of graft thickness, the market is segmented into, split-thickness, full-thickness and composite graft. The split thickness segment held the largest market share and is anticipated to grow at a significant rate during the forecast period as well. Based on application, the market is categorized as, burns, extensive wound, skin cancer, and other applications. The burns segment held the largest share among the applications, due to large number of burn incidences across the globe. Based on equipment, the market is segmented as, dermatome, general surgical instruments, consumables, and others. In 2017, the dermatome segment held a significant share in the market among the equipment. On the basis of end user, the market is segmented as, ambulatory surgical centers, hospitals, and dermatology clinics. In 2017, hospitals held a significant share in the market, owing to the presence of better facilities for conducting the procedure of skin grafting.

Geographically, the market for skin graft is segmented into North America, Europe, Asia Pacific (APC), Middle East and Africa (MEA), and South and Central America (S&CAM). North America has the largest market for skin graft ,due to the availability of better healthcare facilities in the US as well as Canada. Additionally, rise in the number of burn incidences in North America is expected to drive the market in the region during the forecast period. The market of skin graft is expected to witness rapid growth in Asia Pacific during the forecast period. The market of skin graft in Asia Pacific is expected to witness growth owing to, rising prevalence of diabetes, increasing cases of cancers and & burn injuries and rising government initiatives towards women and child health.

TABLE OF CONTENTS

1. INTRODUCTION 25
1.1 SCOPE OF THE STUDY 25
1.1 THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE 25

2. GLOBAL SKIN GRAFT MARKET – KEY TAKEAWAYS 27

3. GLOBAL SKIN GRAFT MARKET – MARKET LANDSCAPE 31
3.1 OVERVIEW 31
3.2 MARKET SEGMENTATION 31
3.3 GLOBAL SKIN GRAFT MARKET – BY TYPE 32
3.4 GLOBAL SKIN GRAFT MARKET – BY GRAFT THICKNESS 32
3.5 GLOBAL SKIN GRAFT MARKET – BY EQUIPMENT 33
3.6 GLOBAL SKIN GRAFT MARKET – BY APPLICATION 33
3.7 GLOBAL SKIN GRAFT MARKET – BY END USER 33
3.8 GLOBAL SKIN GRAFT MARKET – BY GEOGRAPHY 33
3.9 PEST ANALYSIS 34
3.9.1 North America – PEST Analysis 34
3.9.2 Europe – PEST Analysis 36
3.9.3 Asia Pacific– PEST Analysis 38
3.9.4 Middle East And Africa– PEST Analysis 40
3.9.5 South & Central America – PEST Analysis 42

4. GLOBAL SKIN GRAFT MARKET – KEY MARKET DYNAMICS 44
4.1 KEY MARKET DRIVERS 44
4.1.1 Increasing Number Of Burn Injuries 44
4.1.2 Prevalence Of Skin Cancer And Diabetes 44
4.1.3 Increase In The Number Of Conferences, Symposiums And Meetings 45
4.2 KEY MARKET RESTRAINTS 46
4.2.1 Cost Of Skin Grafting Procedures 46
4.2.2 Alternatives For Skin Grafts 46
4.3 KEY MARKET OPPORTUNITIES 47
4.3.1 Increasing Medical Tourism In Emerging Nations 47
4.4 FUTURE TRENDS 47
4.4.1 Research Activities And Product Innovations 47
4.5 IMPACT ANALYSIS 48

5. SKIN GRAFT MARKET – GLOBAL ANALYSIS 49
5.1 GLOBAL SKIN GRAFT MARKET REVENUE FORECASTS AND ANALYSIS 49
5.2 GLOBAL SKIN GRAFT MARKET, BY GEOGRAPHY - FORECASTS AND ANALYSIS 50
5.3 MARKET POSITIONING 51
5.4 PERFORMANCE OF KEY PLAYERS 51
5.4.1 MimMedex 51
5.4.2 Organogenesis 52
5.4.3 Integra LifeSciences 52
5.5 EXPERT OPINIONS 52

6. SKIN GRAFT MARKET – GLOBAL REGULATORY SCENARIO 53
6.1 NORTH AMERICA 53
6.1.1 US 53
6.1.2 Canada 54
6.1.3 Mexico 55
6.2 EUROPE 56
6.3 ASIA PACIFIC 57
6.3.1 Japan 57
6.3.2 China 58
6.3.3 India 59
6.4 MIDDLE EAST & AFRICA 60
6.4.1 Saudi Arabia 60
6.4.2 South Africa 61
6.5 SOUTH & CENTRAL AMERICA 62
6.5.1 Brazil 62